DOJ Opens Investigation Into NYC Coffee Shop Over Anti-Goldman Social Media Post 
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates 
Doncasters Raises $919 Million in NYSE IPO as Aerospace Growth Accelerates 
SK Hynix Targets $29.4 Billion Nasdaq Listing to Expand AI Chip Business 
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy 
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence 
Alibaba Shares Fall After Anthropic Alleges Massive AI Model Distillation Campaign 
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom 
Nissan Halts Electric Qashqai Development Amid EV Market Challenges 
Heineken Names JDE Peet’s CEO Rafael Oliveira as New Chief Executive 
Micron Stock Surges on Strong AI Demand, Record Revenue, and Bullish Q4 Forecast 
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns 
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe 
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White 
Anthropic AI Model Uncovers Vulnerabilities in Classified U.S. Government Systems During Security Test 
Ryan Cohen Rejects GameStop Pay Package, Prepares New eBay Acquisition Plan 
FedEx Stock Drops After Weak 2026 Earnings Forecast Despite Strong Q4 Results 
RALEIGH, N.C., Feb. 26, 2016 -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to Phase IV contract research organization, today announced that Chief Financial Officer Greg Rush is scheduled to present during the upcoming 37th Annual Institutional Investors Conference hosted by Raymond James & Associates in Orlando, Florida on Tuesday, March 8th at 7:30 a.m. Eastern Time.
Links to INC Research’s live presentation and archived audio replay, as well as the presentation materials, will be available via the Company’s Investor Relations website at investor.incresearch.com.
About INC Research
INC Research (Nasdaq:INCR) is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. The Company was named “Best Contract Research Organization” in December 2015 by an independent panel for Scrip Intelligence and ranked “Top CRO to Work With” among large global CROs in the 2015 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, N.C., with operations across six continents and experience spanning more than 100 countries.
Investor Relations Contact: Ronnie Speight Vice President, Investor Relations Phone: +1 (919) 745-2745 Email: [email protected] Press/Media Contact: Lori Dorer Senior Director, Corporate Communications Phone: +1 (513) 763-1380 Email: [email protected]
